{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:04:15Z","timestamp":1785168255301,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:00:00Z","timestamp":1611446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:00:00Z","timestamp":1611446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK085252"],"award-info":[{"award-number":["R01DK085252"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AA025841"],"award-info":[{"award-number":["R21AA025841"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1C1C1004185"],"award-info":[{"award-number":["2020R1C1C1004185"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002507","name":"Kangwon National University","doi-asserted-by":"publisher","award":["2019 Research Grant"],"award-info":[{"award-number":["2019 Research Grant"]}],"id":[{"id":"10.13039\/501100002507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA233452"],"award-info":[{"award-number":["P01CA233452"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12272-021-01309-7","type":"journal-article","created":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T11:02:27Z","timestamp":1611486147000},"page":"230-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient l-amino acid-defined diet-induced murine model"],"prefix":"10.1007","volume":"44","author":[{"given":"Yoon Mee","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michitaka","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9472-6085","authenticated-orcid":false,"given":"Ekihiro","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,24]]},"reference":[{"key":"1309_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/PAP.0b013e318220f59b","volume":"18","author":"FZ Aly","year":"2011","unstructured":"Aly FZ, Kleiner DE (2011) Update on fatty liver disease and steatohepatitis. Adv Anat Pathol 18:294\u2013300. https:\/\/doi.org\/10.1097\/PAP.0b013e318220f59b","journal-title":"Adv Anat Pathol"},{"key":"1309_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246301","author":"IN Andreichenko","year":"2019","unstructured":"Andreichenko IN, Tsitrina AA, Fokin AV, Gabdulkhakova AI, Maltsev DI, Perelman GS, Bulgakova EV, Kulikov AM, Mikaelyan AS, Kotelevtsev YV (2019) 4-Methylumbelliferone prevents liver fibrosis by affecting hyaluronan deposition, FSTL1 expression and cell localization. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20246301","journal-title":"Int J Mol Sci"},{"key":"1309_CR3","doi-asserted-by":"publisher","first-page":"e13577","DOI":"10.1371\/journal.pone.0013577","volume":"5","author":"A Bertola","year":"2010","unstructured":"Bertola A, Bonnafous S, Anty R, Patouraux S, Saint-Paul MC, Iannelli A, Gugenheim J, Barr J, Mato JM, Le Marchand-Brustel Y, Tran A, Gual P (2010) Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS ONE 5:e13577. https:\/\/doi.org\/10.1371\/journal.pone.0013577","journal-title":"PLoS ONE"},{"key":"1309_CR4","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1096\/fj.201500178R","volume":"30","author":"V Bourguignon","year":"2016","unstructured":"Bourguignon V, Flamion B (2016) Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover. FASEB J 30:2108\u20132114. https:\/\/doi.org\/10.1096\/fj.201500178R","journal-title":"FASEB J"},{"key":"1309_CR5","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s10620-017-4724-6","volume":"62","author":"MF Chedid","year":"2017","unstructured":"Chedid MF (2017) Nonalcoholic steatohepatitis: the second leading indication for liver transplantation in the USA. Dig Dis Sci 62:2621\u20132622. https:\/\/doi.org\/10.1007\/s10620-017-4724-6","journal-title":"Dig Dis Sci"},{"key":"1309_CR6","doi-asserted-by":"publisher","first-page":"G433","DOI":"10.1152\/ajpgi.00163.2009","volume":"300","author":"T Csak","year":"2011","unstructured":"Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, Catalano D, Mandrekar P, Dolganiuc A, Kurt-Jones E, Szabo G (2011) Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 300:G433-441. https:\/\/doi.org\/10.1152\/ajpgi.00163.2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1309_CR7","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl AM, Day C (2017) Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med 377:2063\u20132072. https:\/\/doi.org\/10.1056\/NEJMra1503519","journal-title":"N Engl J Med"},{"key":"1309_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/17425255.2017.1314461","volume":"13","author":"CG Dietrich","year":"2017","unstructured":"Dietrich CG, Rau M, Jahn D, Geier A (2017) Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease. Expert Opin Drug Metab Toxicol 13:625\u2013640. https:\/\/doi.org\/10.1080\/17425255.2017.1314461","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1309_CR9","first-page":"167","volume":"67","author":"BF Flanagan","year":"1989","unstructured":"Flanagan BF, Dalchau R, Allen AK, Daar AS, Fabre JW (1989) Chemical composition and tissue distribution of the human CDw44 glycoprotein. Immunology 67:167\u2013175","journal-title":"Immunology"},{"key":"1309_CR10","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s12272-012-0819-y","volume":"35","author":"XX Gao","year":"2012","unstructured":"Gao XX, Shi DH, Chen YX, Cui JT, Wang YR, Jiang CP, Wu JH (2012) The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation. Arch Pharm Res 35:1479\u20131493. https:\/\/doi.org\/10.1007\/s12272-012-0819-y","journal-title":"Arch Pharm Res"},{"key":"1309_CR11","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.lfs.2007.02.037","volume":"80","author":"KS Girish","year":"2007","unstructured":"Girish KS, Kemparaju K (2007) The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci 80:1921\u20131943. https:\/\/doi.org\/10.1016\/j.lfs.2007.02.037","journal-title":"Life Sci"},{"key":"1309_CR12","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/S1470-2045(17)30953-1","volume":"19","author":"E Gourd","year":"2018","unstructured":"Gourd E (2018) PEGPH20 for metastatic pancreatic ductal adenocarcinoma. Lancet Oncol 19:e81. https:\/\/doi.org\/10.1016\/S1470-2045(17)30953-1","journal-title":"Lancet Oncol"},{"key":"1309_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","volume":"71","author":"Haldar D, Kern B, Hodson J, Armstrong MJ, Adam R, Berlakovich G, Fritz J, Feurstein B, Popp W, Karam V, Muiesan P, O'grady J, Jamieson N, Wigmore SJ, Pirenne J, Malek-Hosseini SA, Hidalgo E, Tokat Y, Paul A, Pratschke J, Bartels M, Trunecka P, Settmacher U, Pinzani M, Duvoux C, Newsome PN, Schneeberger S, European L, Intestine Transplant A","year":"2019","unstructured":"Haldar D, Kern B, Hodson J, Armstrong MJ, Adam R, Berlakovich G, Fritz J, Feurstein B, Popp W, Karam V, Muiesan P, O\u2019grady J, Jamieson N, Wigmore SJ, Pirenne J, Malek-Hosseini SA, Hidalgo E, Tokat Y, Paul A, Pratschke J, Bartels M, Trunecka P, Settmacher U, Pinzani M, Duvoux C, Newsome PN, Schneeberger S, European L, Intestine Transplant A (2019) Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study. J Hepatol 71:313\u2013322. https:\/\/doi.org\/10.1016\/j.jhep.2019.04.011","journal-title":"J Hepatol"},{"key":"1309_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","volume":"44","author":"JW Haukeland","year":"2006","unstructured":"Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjoro K, Aukrust P (2006) Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 44:1167\u20131174. https:\/\/doi.org\/10.1016\/j.jhep.2006.02.011","journal-title":"J Hepatol"},{"key":"1309_CR15","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","volume":"162","author":"K Hoshino","year":"1999","unstructured":"Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S (1999) Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749\u20133752","journal-title":"J Immunol"},{"key":"1309_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31031","author":"S Hwang","year":"2019","unstructured":"Hwang S, He Y, Xiang X, Seo W, Kim SJ, Ma J, Ren T, Park SH, Zhou Z, Feng D, Kunos G, Gao B (2019) Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets. Hepatology. https:\/\/doi.org\/10.1002\/hep.31031","journal-title":"Hepatology"},{"key":"1309_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/hep.31031","volume":"72","author":"S Hwang","year":"2020","unstructured":"Hwang S, He Y, Xiang X, Seo W, Kim SJ, Ma J, Ren T, Park SH, Zhou Z, Feng D, Kunos G, Gao B (2020a) Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets. Hepatology 72:412\u2013429. https:\/\/doi.org\/10.1002\/hep.31031","journal-title":"Hepatology"},{"key":"1309_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31390","author":"S Hwang","year":"2020","unstructured":"Hwang S, Wang X, Rodrigues RM, Ma J, He Y, Seo W, Park SH, Kim SJ, Feng D, Gao B (2020b) Protective and detrimental roles of p38alpha MAPK in different stages of nonalcoholic fatty liver disease. Hepatology. https:\/\/doi.org\/10.1002\/hep.31390","journal-title":"Hepatology"},{"key":"1309_CR19","doi-asserted-by":"publisher","first-page":"25085","DOI":"10.1074\/jbc.274.35.25085","volume":"274","author":"N Itano","year":"1999","unstructured":"Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, Mcdonald JA, Kimata K (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274:25085\u201325092. https:\/\/doi.org\/10.1074\/jbc.274.35.25085","journal-title":"J Biol Chem"},{"key":"1309_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1152\/physrev.00052.2009","volume":"91","author":"D Jiang","year":"2011","unstructured":"Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91:221\u2013264. https:\/\/doi.org\/10.1152\/physrev.00052.2009","journal-title":"Physiol Rev"},{"key":"1309_CR21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1315","volume":"11","author":"D Jiang","year":"2005","unstructured":"Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, Noble PW (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11:1173\u20131179. https:\/\/doi.org\/10.1038\/nm1315","journal-title":"Nat Med"},{"key":"1309_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-020-01264-9","author":"SS Kim","year":"2020","unstructured":"Kim SS, Kim HK, Kim H, Lee WT, Lee ES, Oh KT, Choi HG, Youn YS (2020) Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers. Arch Pharm Res. https:\/\/doi.org\/10.1007\/s12272-020-01264-9","journal-title":"Arch Pharm Res"},{"key":"1309_CR23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1053\/j.gastro.2008.12.064","volume":"136","author":"Y Kodama","year":"2009","unstructured":"Kodama Y, Taura K, Miura K, Schnabl B, Osawa Y, Brenner DA (2009) Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis. Gastroenterology 136:1423\u20131434. https:\/\/doi.org\/10.1053\/j.gastro.2008.12.064","journal-title":"Gastroenterology"},{"key":"1309_CR24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F (2017) Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol 17:306\u2013321. https:\/\/doi.org\/10.1038\/nri.2017.11","journal-title":"Nat Rev Immunol"},{"key":"1309_CR25","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1124\/dmd.111.040592","volume":"39","author":"AD Lake","year":"2011","unstructured":"Lake AD, Novak P, Fisher CD, Jackson JP, Hardwick RN, Billheimer DD, Klimecki WT, Cherrington NJ (2011) Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos 39:1954\u20131960. https:\/\/doi.org\/10.1124\/dmd.111.040592","journal-title":"Drug Metab Dispos"},{"key":"1309_CR26","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s12272-019-01178-1","volume":"42","author":"J Lee","year":"2019","unstructured":"Lee J, Park JS, Roh YS (2019) Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease. Arch Pharm Res 42:935\u2013946. https:\/\/doi.org\/10.1007\/s12272-019-01178-1","journal-title":"Arch Pharm Res"},{"key":"1309_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.addr.2015.10.017","volume":"97","author":"J Liang","year":"2016","unstructured":"Liang J, Jiang D, Noble PW (2016) Hyaluronan as a therapeutic target in human diseases. Adv Drug Deliv Rev 97:186\u2013203. https:\/\/doi.org\/10.1016\/j.addr.2015.10.017","journal-title":"Adv Drug Deliv Rev"},{"key":"1309_CR28","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado MV, Diehl AM (2016) Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 150:1769\u20131777. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.066","journal-title":"Gastroenterology"},{"key":"1309_CR29","first-page":"28","volume":"58","author":"V Mahlbacher","year":"1992","unstructured":"Mahlbacher V, Sewing A, Elsasser HP, Kern HF (1992) Hyaluronan is a secretory product of human pancreatic adenocarcinoma cells. Eur J Cell Biol 58:28\u201334","journal-title":"Eur J Cell Biol"},{"key":"1309_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, Tanaka C, Ito T, Katsume A, Sudoh M (2013) An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol 94:93\u2013103. https:\/\/doi.org\/10.1111\/iep.12008","journal-title":"Int J Exp Pathol"},{"key":"1309_CR31","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s10753-014-0092-y","volume":"38","author":"RJ Mckallip","year":"2015","unstructured":"Mckallip RJ, Ban H, Uchakina ON (2015) Treatment with the hyaluronic acid synthesis inhibitor 4-methylumbelliferone suppresses LPS-induced lung inflammation. Inflammation 38:1250\u20131259. https:\/\/doi.org\/10.1007\/s10753-014-0092-y","journal-title":"Inflammation"},{"key":"1309_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","volume":"10","author":"GA Michelotti","year":"2013","unstructured":"Michelotti GA, Machado MV, Diehl AM (2013) NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol 10:656\u2013665. https:\/\/doi.org\/10.1038\/nrgastro.2013.183","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1309_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fimmu.2015.00123","volume":"6","author":"N Nagy","year":"2015","unstructured":"Nagy N, Kuipers HF, Frymoyer AR, Ishak HD, Bollyky JB, Wight TN, Bollyky PL (2015) 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol 6:123. https:\/\/doi.org\/10.3389\/fimmu.2015.00123","journal-title":"Front Immunol"},{"key":"1309_CR34","doi-asserted-by":"publisher","first-page":"7864","DOI":"10.1074\/jbc.RA118.006166","volume":"294","author":"N Nagy","year":"2019","unstructured":"Nagy N, Gurevich I, Kuipers HF, Ruppert SM, Marshall PL, Xie BJ, Sun W, Malkovskiy AV, Rajadas J, Grandoch M, Fischer JW, Frymoyer AR, Kaber G, Bollyky PL (2019) 4-Methylumbelliferyl glucuronide contributes to hyaluronan synthesis inhibition. J Biol Chem 294:7864\u20137877. https:\/\/doi.org\/10.1074\/jbc.RA118.006166","journal-title":"J Biol Chem"},{"key":"1309_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jhep.2017.03.003","volume":"67","author":"S Patouraux","year":"2017","unstructured":"Patouraux S, Rousseau D, Bonnafous S, Lebeaupin C, Luci C, Canivet CM, Schneck AS, Bertola A, Saint-Paul MC, Iannelli A, Gugenheim J, Anty R, Tran A, Bailly-Maitre B, Gual P (2017) CD44 is a key player in non-alcoholic steatohepatitis. J Hepatol 67:328\u2013338. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.003","journal-title":"J Hepatol"},{"key":"1309_CR36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/glycob\/cwr158","volume":"22","author":"F Piccioni","year":"2012","unstructured":"Piccioni F, Malvicini M, Garcia MG, Rodriguez A, Atorrasagasti C, Kippes N, Piedra Buena IT, Rizzo MM, Bayo J, Aquino J, Viola M, Passi A, Alaniz L, Mazzolini G (2012) Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice. Glycobiology 22:400\u2013410. https:\/\/doi.org\/10.1093\/glycob\/cwr158","journal-title":"Glycobiology"},{"key":"1309_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/glycob\/cwv023","volume":"25","author":"F Piccioni","year":"2015","unstructured":"Piccioni F, Fiore E, Bayo J, Atorrasagasti C, Peixoto E, Rizzo M, Malvicini M, Tirado-Gonzalez I, Garcia MG, Alaniz L, Mazzolini G (2015) 4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis. Glycobiology 25:825\u2013835. https:\/\/doi.org\/10.1093\/glycob\/cwv023","journal-title":"Glycobiology"},{"key":"1309_CR38","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1200\/JCO.18.01295","volume":"37","author":"RK Ramanathan","year":"2019","unstructured":"Ramanathan RK, Mcdonough SL, Philip PA, Hingorani SR, Lacy J, Kortmansky JS, Thumar J, Chiorean EG, Shields AF, Behl D, Mehan PT, Gaur R, Seery T, Guthrie KA, Hochster HS (2019) Phase IB\/II randomized study of folfirinox plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313. J Clin Oncol 37:1062\u20131069. https:\/\/doi.org\/10.1200\/JCO.18.01295","journal-title":"J Clin Oncol"},{"key":"1309_CR39","doi-asserted-by":"publisher","first-page":"G30","DOI":"10.1152\/ajpgi.00031.2015","volume":"309","author":"YS Roh","year":"2015","unstructured":"Roh YS, Zhang B, Loomba R, Seki E (2015) TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. Am J Physiol Gastrointest Liver Physiol 309:G30-41. https:\/\/doi.org\/10.1152\/ajpgi.00031.2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1309_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fphys.2012.00213","volume":"3","author":"Y Saiman","year":"2012","unstructured":"Saiman Y, Friedman SL (2012) The role of chemokines in acute liver injury. Front Physiol 3:213. https:\/\/doi.org\/10.3389\/fphys.2012.00213","journal-title":"Front Physiol"},{"issue":"1306\u20131318","key":"1309_CR41","doi-asserted-by":"publisher","first-page":"e1318","DOI":"10.1016\/j.cell.2019.10.018","volume":"179","author":"RT Schinzel","year":"2019","unstructured":"Schinzel RT, Higuchi-Sanabria R, Shalem O, Moehle EA, Webster BM, Joe L, Bar-Ziv R, Frankino PA, Durieux J, Pender C, Kelet N, Kumar SS, Savalia N, Chi H, Simic M, Nguyen NT, Dillin A (2019) The hyaluronidase, TMEM2, promotes ER homeostasis and longevity independent of the UPR(ER). Cell 179(1306\u20131318):e1318. https:\/\/doi.org\/10.1016\/j.cell.2019.10.018","journal-title":"Cell"},{"key":"1309_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, Cabrera D, Arrese M, Feldstein AE (2018) Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol 15:349\u2013364. https:\/\/doi.org\/10.1038\/s41575-018-0009-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1309_CR43","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13:1324\u20131332. https:\/\/doi.org\/10.1038\/nm1663","journal-title":"Nat Med"},{"key":"1309_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cbi.2014.03.003","volume":"216","author":"MO Sim","year":"2014","unstructured":"Sim MO, Ham JR, Lee HI, Seo KI, Lee MK (2014) Long-term supplementation of umbelliferone and 4-methylumbelliferone alleviates high-fat diet induced hypertriglyceridemia and hyperglycemia in mice. Chem Biol Interact 216:9\u201316. https:\/\/doi.org\/10.1016\/j.cbi.2014.03.003","journal-title":"Chem Biol Interact"},{"key":"1309_CR45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s40261-015-0339-x","volume":"35","author":"P Simone","year":"2015","unstructured":"Simone P, Alberto M (2015) Caution should be used in long-term treatment with oral compounds of hyaluronic acid in patients with a history of cancer. Clin Drug Investig 35:689\u2013692. https:\/\/doi.org\/10.1007\/s40261-015-0339-x","journal-title":"Clin Drug Investig"},{"key":"1309_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1078\/0171-9335-00392","volume":"83","author":"R Stern","year":"2004","unstructured":"Stern R (2004) Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 83:317\u2013325. https:\/\/doi.org\/10.1078\/0171-9335-00392","journal-title":"Eur J Cell Biol"},{"key":"1309_CR47","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0016-5085(96)70074-4","volume":"111","author":"S Tamaki","year":"1996","unstructured":"Tamaki S, Ueno T, Torimura T, Sata M, Tanikawa K (1996) Evaluation of hyaluronic acid binding ability of hepatic sinusoidal endothelial cells in rats with liver cirrhosis. Gastroenterology 111:1049\u20131057","journal-title":"Gastroenterology"},{"key":"1309_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL (2017) Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14:397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1309_CR49","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jcmgh.2016.12.004","volume":"3","author":"L Yang","year":"2017","unstructured":"Yang L, Miura K, Zhang B, Matsushita H, Yang YM, Liang S, Song J, Roh YS, Seki E (2017) TRIF differentially regulates hepatic steatosis and inflammation\/fibrosis in mice. Cell Mol Gastroenterol Hepatol 3:469\u2013483. https:\/\/doi.org\/10.1016\/j.jcmgh.2016.12.004","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1309_CR50","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fendo.2018.00378","volume":"9","author":"YM Yang","year":"2018","unstructured":"Yang YM, Fukui M, Wang Z, Miao F, Karriker MJ, Seki E (2018) Interventional potential of recombinant feline hepatocyte growth factor in a mouse model of non-alcoholic steatohepatitis. Front Endocrinol (Lausanne) 9:378. https:\/\/doi.org\/10.3389\/fendo.2018.00378","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1309_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat9284","author":"YM Yang","year":"2019","unstructured":"Yang YM, Noureddin M, Liu C, Ohashi K, Kim SY, Ramnath D, Powell EE, Sweet MJ, Roh YS, Hsin IF, Deng N, Liu Z, Liang J, Mena E, Shouhed D, Schwabe RF, Jiang D, Lu SC, Noble PW, Seki E (2019) Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aat9284","journal-title":"Sci Transl Med"},{"key":"1309_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv085","author":"TJ Yates","year":"2015","unstructured":"Yates TJ, Lopez LE, Lokeshwar SD, Ortiz N, Kallifatidis G, Jordan A, Hoye K, Altman N, Lokeshwar VB (2015) Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv085","journal-title":"J Natl Cancer Inst"},{"key":"1309_CR53","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1136\/gutjnl-2011-300269","volume":"61","author":"D Ye","year":"2012","unstructured":"Ye D, Li FY, Lam KS, Li H, Jia W, Wang Y, Man K, Lo CM, Li X, Xu A (2012) Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice. Gut 61:1058\u20131067. https:\/\/doi.org\/10.1136\/gutjnl-2011-300269","journal-title":"Gut"},{"key":"1309_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat0344","author":"C Zhu","year":"2018","unstructured":"Zhu C, Kim K, Wang X, Bartolome A, Salomao M, Dongiovanni P, Meroni M, Graham MJ, Yates KP, Diehl AM, Schwabe RF, Tabas I, Valenti L, Lavine JE, Pajvani UB (2018) Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aat0344","journal-title":"Sci Transl Med"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-021-01309-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-021-01309-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-021-01309-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:06:41Z","timestamp":1697674001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-021-01309-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,24]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1007\/s12272-021-01309-7","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,24]]},"assertion":[{"value":"5 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}